Aurobindo Pharma receives USFDA approval for Memantine Hydrochloride tablets

Aurobindo Pharma has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Memantine Hydrochloride Tablets, 5mg and 10mg.

October 15, 2015 / 10:48 IST

Aurobindo Pharma Ltd has submitted to BSE a copy of Press Release dated October 15, 2015 titled "Aurobindo Pharma receives USFDA Approval for Memantine Hydrochloride Tablets".Source : BSE

Read all announcements in Aurobindo Pharm

first published: Oct 15, 2015 10:48 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Aurobindo Pharma receives USFDA approval for Memantine Hydrochloride tablets

Aurobindo Pharma has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Memantine Hydrochloride Tablets, 5mg and 10mg.

AP